These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 7482387)

  • 21. The role of glutamate in central nervous system health and disease--a review.
    Platt SR
    Vet J; 2007 Mar; 173(2):278-86. PubMed ID: 16376594
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cobalt accumulation in neurons expressing ionotropic excitatory amino acid receptors in young rat spinal cord: morphology and distribution.
    Nagy I; Woolf CJ; Dray A; Urbán L
    J Comp Neurol; 1994 Jun; 344(3):321-35. PubMed ID: 8063957
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glutamatergic neurotransmission modulators as emerging new drugs for schizophrenia.
    Heresco-Levy U
    Expert Opin Emerg Drugs; 2005 Nov; 10(4):827-44. PubMed ID: 16262565
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protein retention in the endoplasmic reticulum, blockade of programmed cell death and autophagy selectively occur in spinal cord motoneurons after glutamate receptor-mediated injury.
    Tarabal O; Calderó J; Casas C; Oppenheim RW; Esquerda JE
    Mol Cell Neurosci; 2005 Jun; 29(2):283-98. PubMed ID: 15911352
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LY503430, a novel alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor potentiator with functional, neuroprotective and neurotrophic effects in rodent models of Parkinson's disease.
    Murray TK; Whalley K; Robinson CS; Ward MA; Hicks CA; Lodge D; Vandergriff JL; Baumbarger P; Siuda E; Gates M; Ogden AM; Skolnick P; Zimmerman DM; Nisenbaum ES; Bleakman D; O'Neill MJ
    J Pharmacol Exp Ther; 2003 Aug; 306(2):752-62. PubMed ID: 12730350
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NR1 and GluR2 expression mediates excitotoxicity in chronic hypobaric hypoxia.
    Hota SK; Barhwal K; Singh SB; Sairam M; Ilavazhagan G
    J Neurosci Res; 2008 Apr; 86(5):1142-52. PubMed ID: 17969105
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Competitive AMPA receptor antagonists.
    Catarzi D; Colotta V; Varano F
    Med Res Rev; 2007 Mar; 27(2):239-78. PubMed ID: 16892196
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contribution of spinal glutamatergic receptors to the antinociception caused by agmatine in mice.
    Gadotti VM; Tibola D; Paszcuk AF; Rodrigues AL; Calixto JB; Santos AR
    Brain Res; 2006 Jun; 1093(1):116-22. PubMed ID: 16765330
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel approaches to targeting glutamate receptors for the treatment of chronic pain: review article.
    Chizh BA
    Amino Acids; 2002; 23(1-3):169-76. PubMed ID: 12373533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Death of septal cholinergic neurons produced by chronic exposure to glutamate is prevented by the noncompetitive NMDA receptor/channel antagonist, MK-801: role of nerve growth factor and nitric oxide.
    Michel PP; Agid Y
    J Neurosci Res; 1995 Apr; 40(6):764-75. PubMed ID: 7629890
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Excitatory amino-acids, a new class of neurotransmitters. Pharmacology and functional properties].
    Krebs MO
    Encephale; 1992; 18(3):271-9. PubMed ID: 1363728
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Excitotoxic cell death.
    Choi DW
    J Neurobiol; 1992 Nov; 23(9):1261-76. PubMed ID: 1361523
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: epilepsy, encephalitis, cerebellar ataxia, systemic lupus erythematosus (SLE) and neuropsychiatric SLE, Sjogren's syndrome, schizophrenia, mania or stroke. These autoimmune anti-glutamate receptor antibodies can bind neurons in few brain regions, activate glutamate receptors, decrease glutamate receptor's expression, impair glutamate-induced signaling and function, activate blood brain barrier endothelial cells, kill neurons, damage the brain, induce behavioral/psychiatric/cognitive abnormalities and ataxia in animal models, and can be removed or silenced in some patients by immunotherapy.
    Levite M
    J Neural Transm (Vienna); 2014 Aug; 121(8):1029-75. PubMed ID: 25081016
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Excitotoxicity and amyotrophic lateral sclerosis.
    Van Damme P; Dewil M; Robberecht W; Van Den Bosch L
    Neurodegener Dis; 2005; 2(3-4):147-59. PubMed ID: 16909020
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular and cellular mechanisms of excitotoxic neuronal death.
    Wang Y; Qin ZH
    Apoptosis; 2010 Nov; 15(11):1382-402. PubMed ID: 20213199
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glutamate dysfunction and selective motor neuron degeneration in amyotrophic lateral sclerosis: a hypothesis.
    Plaitakis A
    Ann Neurol; 1990 Jul; 28(1):3-8. PubMed ID: 1973889
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Excitatory amino acid receptors and disease.
    Meldrum BS
    Curr Opin Neurol Neurosurg; 1992 Aug; 5(4):508-13. PubMed ID: 1325224
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Excitotoxic mechanisms, and age-related susceptibility to brain damage in ischemia, hypoglycemia and toxic mussel poisoning.
    Auer RN
    Neurotoxicology; 1991; 12(3):541-6. PubMed ID: 1684035
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanisms of excitotoxicity in neurologic diseases.
    Beal MF
    FASEB J; 1992 Dec; 6(15):3338-44. PubMed ID: 1464368
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Molecular operation of ionotropic glutamate receptors: proteins that mediate the excitatory synaptic neurotransmission].
    Gielen M
    Med Sci (Paris); 2010 Jan; 26(1):65-72. PubMed ID: 20132777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.